• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估胰岛素抵抗指数(HOMA-IR)在妊娠期糖尿病中的预测价值:一项来自罗马尼亚的病例对照研究。

Evaluating the Predictive Value of HOMA-IR in Gestational Diabetes: A Case-Control Study from Romania.

作者信息

Iman Ait El Haj, Onel Cristina, Furau Gheorghe, Furau Cristian, Furau Roxana, Lucan Mihai, Sandor Mircea, Sachelarie Liliana, Huniadi Anca

机构信息

Department of Clinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1st December Square 10, 410073 Oradea, Romania.

Department of Obstetrics and Gynecology, Western University "Vasile Goldis" of Arad, 310025 Arad, Romania.

出版信息

Diagnostics (Basel). 2025 Jul 3;15(13):1704. doi: 10.3390/diagnostics15131704.

DOI:10.3390/diagnostics15131704
PMID:40647703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12248977/
Abstract

Gestational diabetes mellitus (GDM) is a common metabolic disorder during pregnancy, associated with increased risks for both maternal and fetal complications. Insulin resistance plays a central role in its pathophysiology. This study aimed to evaluate the predictive value of the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) in diagnosing GDM and to explore its correlation with clinical and anthropometric parameters in a Romanian population. A retrospective case-control study was conducted on 320 pregnant women between 24 and 28 weeks of gestation. Based on ADA criteria, participants were divided into 160 with GDM and 160 controls, matched by age and gestational week. Fasting glucose, insulin, BMI, and blood pressure were assessed. HOMA-IR and HOMA-β were calculated. Statistical analyses included -tests, Pearson correlation, and logistic regression. : HOMA-IR was significantly higher in the GDM group (2.9 vs. 1.8; < 0.001). It correlated with fasting insulin (r = 0.85, < 0.001), fasting glucose (r = 0.65, < 0.001), BMI (r = 0.60, < 0.001), and systolic blood pressure (r = 0.42, < 0.001). Logistic regression identified HOMA-IR as an independent predictor of GDM (OR = 2.4, 95% CI: 1.6-3.5, < 0.001), along with BMI ( = 0.01) and maternal age ( = 0.05). HOMA-IR is significantly associated with GDM and may enhance mid-gestational risk assessment when combined with clinical and anthropometric measures. Further studies are needed to validate its predictive accuracy in broader populations.

摘要

妊娠期糖尿病(GDM)是孕期常见的代谢紊乱疾病,与母婴并发症风险增加相关。胰岛素抵抗在其病理生理过程中起核心作用。本研究旨在评估胰岛素抵抗稳态模型评估(HOMA-IR)在诊断GDM中的预测价值,并探讨其与罗马尼亚人群临床及人体测量学参数的相关性。对320名妊娠24至28周的孕妇进行了一项回顾性病例对照研究。根据美国糖尿病协会(ADA)标准,将参与者分为160例GDM患者和160例对照,按年龄和孕周匹配。评估空腹血糖、胰岛素、体重指数(BMI)和血压。计算HOMA-IR和HOMA-β。统计分析包括t检验、Pearson相关性分析和逻辑回归。结果显示:GDM组的HOMA-IR显著更高(2.9对1.8;P<0.001)。它与空腹胰岛素(r = 0.85,P<0.001)、空腹血糖(r = 0.65,P<0.001)、BMI(r = 0.60,P<0.001)和收缩压(r = 0.42,P<0.001)相关。逻辑回归确定HOMA-IR是GDM的独立预测因子(OR = 2.4,95%置信区间:1.6 - 3.5,P<0.001),同时还有BMI(P = 0.01)和母亲年龄(P = 0.05)。HOMA-IR与GDM显著相关,与临床和人体测量指标联合使用时可增强孕中期风险评估。需要进一步研究以验证其在更广泛人群中的预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/12248977/7705ac45cb47/diagnostics-15-01704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/12248977/7705ac45cb47/diagnostics-15-01704-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddcd/12248977/7705ac45cb47/diagnostics-15-01704-g001.jpg

相似文献

1
Evaluating the Predictive Value of HOMA-IR in Gestational Diabetes: A Case-Control Study from Romania.评估胰岛素抵抗指数(HOMA-IR)在妊娠期糖尿病中的预测价值:一项来自罗马尼亚的病例对照研究。
Diagnostics (Basel). 2025 Jul 3;15(13):1704. doi: 10.3390/diagnostics15131704.
2
Different intensities of glycaemic control for women with gestational diabetes mellitus.不同强度的血糖控制对妊娠期糖尿病妇女的影响。
Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3.
3
Gestational diabetes mellitus (GDM): diagnosis using biochemical parameters and anthropometric measurements during the first trimester in the Indian population.妊娠期糖尿病(GDM):印度人群孕早期使用生化参数和人体测量学指标进行诊断
Horm Mol Biol Clin Investig. 2024 Nov 12;46(2):77-83. doi: 10.1515/hmbci-2024-0040. eCollection 2025 Jun 1.
4
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.孕期女性产前补充肌醇以预防妊娠期糖尿病。
Cochrane Database Syst Rev. 2015 Dec 17;2015(12):CD011507. doi: 10.1002/14651858.CD011507.pub2.
5
Different intensities of glycaemic control for women with gestational diabetes mellitus.妊娠期糖尿病女性不同强度的血糖控制
Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2.
6
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.诊断妊娠期糖尿病以改善母婴健康的不同策略。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD007122. doi: 10.1002/14651858.CD007122.pub4.
7
Prevalence and Risk Factors of Preeclampsia in Pregnant Women With Gestational Diabetes Mellitus.妊娠期糖尿病孕妇中先兆子痫的患病率及危险因素
Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-13. doi: 10.12968/hmed.2024.0990. Epub 2025 Jun 20.
8
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.基于不同风险特征和环境进行妊娠期糖尿病筛查以改善母婴健康。
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
9
Exercise for pregnant women with gestational diabetes for improving maternal and fetal outcomes.妊娠期糖尿病孕妇运动对改善母婴结局的作用
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012202. doi: 10.1002/14651858.CD012202.pub2.
10
Relationship between serum levels of ANGPTL8, Apo C2, and human placental lactogen (hPL) in patients with gestational diabetes mellitus: Interaction of LPL regulators with hPL, a possible contributing factor to insulin resistance.妊娠期糖尿病患者血清血管生成素样蛋白8(ANGPTL8)、载脂蛋白C2(Apo C2)与人类胎盘催乳素(hPL)水平之间的关系:脂蛋白酶(LPL)调节剂与hPL的相互作用,胰岛素抵抗的一个可能促成因素。
Placenta. 2025 Jan;159:119-125. doi: 10.1016/j.placenta.2024.12.007. Epub 2024 Dec 12.

本文引用的文献

1
Early Prediction of Gestational Diabetes Mellitus and Insulin Therapy Requirement Using First-Trimester PAPP-A and Free β-hCG MoMs Levels: A Retrospective Case-Control Study.利用孕早期妊娠相关血浆蛋白A(PAPP-A)和游离β-人绒毛膜促性腺激素(β-hCG)中位数倍数(MoMs)水平对妊娠期糖尿病及胰岛素治疗需求进行早期预测:一项回顾性病例对照研究
J Clin Med. 2024 Dec 18;13(24):7725. doi: 10.3390/jcm13247725.
2
Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus.生化标志物对妊娠期糖尿病的诊断和预后的预测价值。
Int J Mol Sci. 2024 Oct 30;25(21):11666. doi: 10.3390/ijms252111666.
3
The yield of early-pregnancy homeostasis of model assessment -insulin resistance (HOMA-IR) for predicting gestational diabetes mellitus in different body mass index and age groups.
早孕期模型评估-胰岛素抵抗(HOMA-IR)对不同体重指数和年龄组预测妊娠糖尿病的应用。
BMC Pregnancy Childbirth. 2023 Nov 28;23(1):822. doi: 10.1186/s12884-023-06113-3.
4
Predictability of HOMA-IR for Gestational Diabetes Mellitus in Early Pregnancy Based on Different First Trimester BMI Values.基于孕早期不同体重指数值的HOMA-IR对早期妊娠合并妊娠期糖尿病的预测性
J Pers Med. 2022 Dec 28;13(1):60. doi: 10.3390/jpm13010060.
5
A Clinical Update on Gestational Diabetes Mellitus.妊娠期糖尿病的临床新进展。
Endocr Rev. 2022 Sep 26;43(5):763-793. doi: 10.1210/endrev/bnac003.
6
Correlation of Insulin Resistance in Pregnancy with Obstetric Outcome.孕期胰岛素抵抗与产科结局的相关性
J Obstet Gynaecol India. 2021 Oct;71(5):495-500. doi: 10.1007/s13224-021-01426-9. Epub 2021 May 24.
7
Associations of maternal insulin resistance during pregnancy and offspring inflammation at birth and at 5 years of age: A prospective study in the Gen3G cohort.妊娠期间母体胰岛素抵抗与出生时及 5 岁时后代炎症的相关性:Gen3G 队列的前瞻性研究。
Cytokine. 2021 Oct;146:155636. doi: 10.1016/j.cyto.2021.155636. Epub 2021 Jul 13.
8
Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia.健康妊娠、妊娠期糖尿病和子痫前期的脂肪组织功能。
Eur J Clin Nutr. 2021 Dec;75(12):1745-1756. doi: 10.1038/s41430-021-00948-9. Epub 2021 Jun 15.
9
Lifestyle intervention to prevent gestational diabetes mellitus and adverse maternal outcomes among pregnant women at high risk for gestational diabetes mellitus.生活方式干预预防妊娠期糖尿病及不良母婴结局在患有妊娠期糖尿病高危风险的孕妇中。
J Int Med Res. 2020 Dec;48(12):300060520979130. doi: 10.1177/0300060520979130.
10
14. Management of Diabetes in Pregnancy: .14. 妊娠期间糖尿病的管理:
Diabetes Care. 2021 Jan;44(Suppl 1):S200-S210. doi: 10.2337/dc21-S014.